ORA-TESTRYL Drug Patent Profile
Which patents cover Ora-testryl, and when can generic versions of Ora-testryl launch?
Ora-testryl is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in ORA-TESTRYL is fluoxymesterone. There is one drug master file entry for this compound. Additional details are available on the fluoxymesterone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ORA-TESTRYL?
- What are the global sales for ORA-TESTRYL?
- What is Average Wholesale Price for ORA-TESTRYL?
Summary for ORA-TESTRYL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 47 |
| Patent Applications: | 4,954 |
| DailyMed Link: | ORA-TESTRYL at DailyMed |
US Patents and Regulatory Information for ORA-TESTRYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | ORA-TESTRYL | fluoxymesterone | TABLET;ORAL | 011359-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bristol Myers Squibb | ORA-TESTRYL | fluoxymesterone | TABLET;ORAL | 011359-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
